Basit öğe kaydını göster

dc.contributor.authorTopuz, O.
dc.contributor.authorTukenmez, Mustafa
dc.contributor.authorKeceli, M.
dc.contributor.authorSozen, S.
dc.date.accessioned2021-03-06T11:18:15Z
dc.date.available2021-03-06T11:18:15Z
dc.date.issued2011
dc.identifier.citationSozen S., Topuz O., Tukenmez M., Keceli M., "The use of fibrin sealant after total thyroidectomy for benign disease obviates the need for routine drainage. Results of a randomized controlled trial", HIPPOKRATIA, cilt.15, ss.247-251, 2011
dc.identifier.issn1108-4189
dc.identifier.otherav_ee639f83-b668-4538-8939-e3b64110f089
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/156492
dc.description.abstractBackground: Drains are usually left after thyroid surgery to prevent formation of hematoma and seroma in the thyroid bed. This prospective randomized clinical trial was conducted to evaluate the necessity of drainage after total thyroidectomy for benign thyroidal disorders.
dc.language.isoeng
dc.subjectAssessment and Diagnosis
dc.subjectTıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectFamily Practice
dc.subjectFundamentals and Skills
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectInternal Medicine
dc.subjectKlinik Tıp (MED)
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectHealth Sciences
dc.titleThe use of fibrin sealant after total thyroidectomy for benign disease obviates the need for routine drainage. Results of a randomized controlled trial
dc.typeMakale
dc.relation.journalHIPPOKRATIA
dc.contributor.departmentKayseri Training & Res Hosp Gen Surg , ,
dc.identifier.volume15
dc.identifier.issue3
dc.identifier.startpage247
dc.identifier.endpage251
dc.contributor.firstauthorID2481957


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster